← All companies

AXIM

AXIM Biotechnologies, Inc.

AXIM OTC Pharmaceutical Preparations EDGAR ↗

$0.00

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$1.44M

Revenue (TTM)

$92.7K

Net income (TTM)

-$4.14M

EPS (TTM)

$-0.02

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$6.04K

Total assets

$3.73M

Gross margin

—

52-week range

$0.00 – $0.03

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Change in control; Director or officer change Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 10-Q/A Quarter ended 2024-03-31 May 22, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 10-K Fiscal year ended 2023-12-31 Apr 16, 2024 8-K Entered a material agreement; Took on a direct financial obligation Mar 21, 2024 8-K Entered a material agreement; Unregistered sale of equity Feb 13, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 28, 2023 10-Q Quarter ended 2023-09-30 Nov 20, 2023 10-Q Quarter ended 2023-06-30 Aug 21, 2023 8-K Entered a material agreement Jun 2, 2023 8-K Entered a material agreement; Took on a direct financial obligation May 30, 2023 8-K Director or officer change May 25, 2023 10-Q Quarter ended 2023-03-31 May 22, 2023 10-K Fiscal year ended 2022-12-31 Apr 17, 2023 8-K Entered a material agreement; Took on a direct financial obligation Jan 27, 2023 10-Q/A Quarter ended 2022-09-30 Nov 15, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Entered a material agreement; Regulation FD disclosure Sep 19, 2022 8-K Entered a material agreement; Unregistered sale of equity Aug 29, 2022 10-Q Quarter ended 2022-06-30 Aug 16, 2022 10-Q Quarter ended 2022-03-31 May 23, 2022 10-K/A Fiscal year ended 2021-12-31 Apr 19, 2022 10-K Fiscal year ended 2021-12-31 Apr 15, 2022 8-K Terminated a material agreement; Regulation FD disclosure Mar 9, 2022 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Feb 16, 2022 8-K Director or officer change Jan 12, 2022 8-K Director or officer change Jan 7, 2022 10-Q Quarter ended 2021-09-30 Nov 22, 2021 10-Q Quarter ended 2021-06-30 Aug 23, 2021 8-K Entered a material agreement; Regulation FD disclosure Aug 4, 2021 10-Q/A Quarter ended 2021-03-31 Jun 2, 2021 10-Q Quarter ended 2021-03-31 May 24, 2021 8-K Entered a material agreement May 14, 2021 10-K/A Fiscal year ended 2020-12-31 Apr 26, 2021 10-K Fiscal year ended 2020-12-31 Apr 15, 2021 10-Q/A Quarter ended 2020-09-30 Nov 27, 2020 10-Q Quarter ended 2020-09-30 Nov 20, 2020 10-Q/A Quarter ended 2020-06-30 Aug 18, 2020 10-Q Quarter ended 2020-06-30 Aug 14, 2020